Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1369500A details a novel chemical synthesis for bioactive Panax notoginseng polysaccharide fragments, offering high-purity pharmaceutical intermediates with scalable production capabilities.
Patent CN101671376B details a novel 4-step synthesis of alkannin acetyl glucose. Discover cost-effective manufacturing and high-purity anti-tumor intermediates.
Novel patent CN120842292A offers shortened route for resveratrol glycosides. High purity beta-configuration suitable for osteoarthritis drug manufacturing.
Patent CN113735921B details a scalable synthesis for C-glycoside impurities, enhancing QC capabilities and reducing costs in API manufacturing for global supply chains.
Patent CN115925756B details a high-stereoselective TN antigen preparation method avoiding noble metals, offering cost reduction and supply chain reliability for vaccine developers.
Novel process for Edaravone glucuronide offering superior yield and purity, enabling reliable supply for metabolic studies and API development.
Patent CN100537589C details a high-yield, chromatography-free synthesis of 2-deoxy-beta-adenosine, offering significant cost reduction and scalable production for pharmaceutical manufacturers.
Novel tin tetrachloride catalyzed route for Sofosbuvir intermediate. High yield, optical purity, scalable manufacturing solution for pharma supply chains.
Patent CN111518148A reveals a green synthesis for gastrodin intermediates. Achieve higher yields and lower costs with our scalable manufacturing solutions.
Novel triethylamine catalyzed method for Bromotetraacetylglucose. Enhances purity and safety for pharmaceutical intermediate supply chains.
Patent CN118724988A reveals a novel glycosylation method enhancing nucleic acid delivery carrier synthesis with improved scalability and purity for pharmaceutical applications.
Patent CN113234113A details organic catalysis for 1,2-cis-glycosidic bonds. Enhances supply chain reliability and cost efficiency for vaccine antigen manufacturing.
Novel cis-double bond α-glycosylceramide isomer synthesis patent offers high stereoselectivity and cost-effective manufacturing for immunotherapy intermediates.
Patent CN108822170B reveals novel anthraquinone imidazole riboside analogues with improved solubility and anticancer activity, offering scalable synthetic routes for pharmaceutical intermediates.
Patent CN101215303B details a six-step synthesis for xylosyl thiourea heterocyclic compounds. This report analyzes cost reduction in API manufacturing and supply chain reliability for oncology intermediates.
Patent CN101215305B details a novel six-step synthesis for glucosyl thiourea derivatives. Discover cost-effective manufacturing and supply chain solutions for high-purity antitumor intermediates.
Patent CN101215304B details a novel six-step synthesis for lactosyl thiourea derivatives. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity antineoplastic intermediates.
Patent CN101307078B details a robust six-step synthesis for galactosyl thiourea heterocycles, offering significant cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN101628927A details a stereoselective route for Gemcitabine. Discover cost reduction in pharmaceutical manufacturing and high-purity oncology intermediates.
Patent CN110627845A details a high-yield Rosavin synthesis. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.